Yes, ketamine can cause hallucinations, but they tend to be different from the vivid visual experiences people associate with classic psychedelics like psilocybin or LSD. Ketamine’s primary effect is dissociation, a feeling of detachment from your body and surroundings, and hallucinations may or may not accompany that depending on the dose and the setting you’re in.
What Ketamine’s Hallucinations Feel Like
Ketamine is classified as a dissociative anesthetic, not a psychedelic, and that distinction shapes the kind of sensory changes it produces. The most common experience is a shift in body awareness: floating sensations, feeling detached from your limbs, or a sense that your body has changed shape or size. These body-level distortions show up more reliably than any visual effects.
Visual hallucinations can occur, but they’re less prominent than with classic psychedelics. This has a straightforward biological explanation. The receptors ketamine blocks are distributed evenly across the brain, without a high concentration in visual processing areas. Classic psychedelics like psilocybin, by contrast, activate receptors that are densely packed in visual regions, which is why they so reliably produce vivid colors, patterns, and imagery. With ketamine, people are more likely to describe dreamlike states, shifting perceptions of space, and a sense that time has slowed or stopped than to report the kaleidoscopic visuals typical of a psilocybin experience.
That said, the setting matters. Research published in the journal Psychopathology found that when environmental stimulation is minimized (a quiet, dark room, for instance), the brain compensates by amplifying its own internal predictions about what it should be perceiving. This “filling in the blanks” process can generate experience-based hallucinations, meaning images, sounds, or scenes drawn from memory rather than abstract geometric patterns.
Dissociation vs. True Hallucination
Many people use the word “hallucination” loosely, and with ketamine the line between dissociation and hallucination gets blurry. Researchers distinguish between the two by looking at which brain networks are disrupted. Ketamine appears to produce its dissociative effects by disrupting the brain’s salience network, which normally helps you track what’s happening to your body and decide what deserves attention. When that network is thrown off, you feel disconnected, floaty, and disoriented. These sensations can feel strange enough that people describe them as hallucinatory, even though they don’t involve seeing or hearing things that aren’t there.
Separately, ketamine can also disrupt the default mode network, which is involved in your sense of personal identity and narrative self. When this happens, the experience looks more like what you’d expect from a psychedelic: a sense of ego dissolution, deep emotional content, or mystical-feeling states. This “psychedelic” side of ketamine is more dependent on context, meaning the environment and the person’s mindset, while the dissociative side tends to show up regardless of setting.
How Dose Changes the Experience
The intensity of perceptual changes scales directly with dose, and the ranges are well defined. At low, pain-relieving doses (roughly 0.1 to 0.3 mg/kg given intravenously), most people experience mild lightheadedness or a slight sense of unreality, with little to no hallucinatory content. This is the range commonly used in clinical infusions for depression.
At moderate doses (0.4 to 0.8 mg/kg IV), partial dissociation sets in. Perception of time and space begins to warp, body awareness changes noticeably, and some people report closed-eye imagery or a dreamlike quality to their thoughts. True hallucinations are possible but not guaranteed.
At full dissociative doses (1 to 2 mg/kg IV, or 2 to 4 mg/kg when injected into a muscle), the person may become completely unresponsive to their environment. This is the territory sometimes called a “K-hole,” where the sense of being in a body or a room can vanish entirely, replaced by immersive, dream-like experiences that can feel profoundly real. These high-dose states are the most likely to include what most people would recognize as hallucinations.
Hallucinations During Recovery From Anesthesia
When ketamine is used as a surgical anesthetic, a well-known side effect is what clinicians call emergence phenomena: hallucinations, vivid dreams, or agitation that occur as the drug wears off. The incidence ranges from 5% to 30% of patients, and it’s mostly dose-related.
In one study tracking patients after ketamine anesthesia, about 13 to 17% experienced mild emergence delirium (purposeless or hallucinatory movements) in the first two hours after surgery. Vivid dreams were even more common, reported by 20 to 27% of patients in the first hour. Severe reactions, involving screaming or violent involuntary movements, were rare, occurring in about 3% of cases. These effects are temporary, typically resolving within two hours as the drug clears the system.
Why Ketamine Causes These Effects
Ketamine works by blocking NMDA receptors, which are one of the brain’s main tools for processing the neurotransmitter glutamate. Glutamate is the brain’s primary excitatory chemical messenger, involved in nearly every cognitive function. When ketamine blocks NMDA receptors, it doesn’t simply quiet the brain down. Instead, it creates an imbalance: the signals traveling “bottom-up” from your senses get amplified, while the “top-down” signals your brain uses to interpret and filter those senses get suppressed.
The result is that raw sensory noise gets turned up, but your brain’s ability to make coherent sense of that noise is impaired. Your brain then tries to compensate by relying more heavily on prior expectations and memories, essentially guessing at what’s happening. When the guessing becomes vivid enough, you experience it as a hallucination. This is why ketamine-induced hallucinations often have a personal, memory-based quality rather than the abstract geometric patterns more typical of classic psychedelics.
How Setting Shapes the Experience
One practical takeaway from the research is that environment plays a significant role in whether ketamine produces hallucinations. In a stimulating environment with light, sound, and conversation, the brain has enough real sensory information to work with, and the experience tends to stay in the dissociative range: strange body sensations, detachment, altered time perception. In a quiet, dark room, the brain has less external input to anchor itself, and it compensates by generating more internal imagery. This is one reason clinical ketamine sessions often use eyeshades and calming music: a controlled sensory environment helps keep the experience predictable.
Personal factors also matter. People with a rich visual imagination or those who are prone to absorptive mental states (getting deeply lost in music, daydreams, or stories) tend to report more vivid perceptual changes. Prior experience with altered states, anxiety levels, and expectations all influence whether the experience tips toward mild dissociation or full-blown hallucinatory content.